Zou L - Search Results

1

Down-regulation of CCL17 in cancer-associated fibroblasts inhibits cell migration and invasion of breast cancer through ERK1/2 pathway.

Li J, Yang C, Yang J, Zou L. Li J, et al. Among authors: zou l. Cancer Manag Res. 2019 Aug 7;11:7439-7453. doi: 10.2147/CMAR.S211651. eCollection 2019. Cancer Manag Res. 2019. Retraction in: Cancer Manag Res. 2020 Sep 08;12:8115. doi: 10.2147/CMAR.S279114 PMID: 31496803 Free PMC article. Retracted.

2

Clinical efficacy of bortezomib and lenalidomide in blastic plasmacytoid dendritic cell neoplasm.

Yang C, Fu C, Feng Y, Zhao S, Weng H, Zhang L, Du H, Zou L. Yang C, et al. Among authors: zou l. Ann Hematol. 2019 Jun;98(6):1525-1527. doi: 10.1007/s00277-019-03623-z. Epub 2019 Jan 29. Ann Hematol. 2019. PMID: 30694364 No abstract available.

3

Nasal-Type Extranodal Natural Killer/T Cell Lymphoma with Meningeal Involvement: A Case Report and Literature Review.

Yang C, Zhuo H, Zou L. Yang C, et al. Among authors: zou l. Indian J Hematol Blood Transfus. 2020 Apr;36(2):381-383. doi: 10.1007/s12288-019-01234-2. Epub 2019 Nov 30. Indian J Hematol Blood Transfus. 2020. PMID: 32425394 Free PMC article.

4

Glans metastatic extra-nodal natural killer/T-cell lymphoma, nasal-type with HDAC inhibitor as maintenance therapy: a rare case report with literature review.

Fu C, Yang C, Li Q, Wang L, Zou L. Fu C, et al. Among authors: zou l. Ann Palliat Med. 2020 Sep;9(5):3602-3608. doi: 10.21037/apm-19-430b. Epub 2020 May 27. Ann Palliat Med. 2020. PMID: 32527129 Free article. Review.

5

A novel nomogram based on prognostic factors for predicting venous thrombosis risk in lymphoma patients.

Yang J, Zhang Y, Yang P, Zhang X, Li M, Zou L. Yang J, et al. Among authors: zou l. Leuk Lymphoma. 2021 Oct;62(10):2383-2391. doi: 10.1080/10428194.2021.1913149. Epub 2021 May 8. Leuk Lymphoma. 2021. PMID: 33966585

6

Prognostic Role of Blood Markers in Primary Central Nervous System Lymphoma Patients Treated With High-Dose Methotrexate-Based Therapy.

Luo Q, Yang C, Fu C, Wu W, Wei Y, Zou L. Luo Q, et al. Among authors: zou l. Front Oncol. 2021 Apr 29;11:639644. doi: 10.3389/fonc.2021.639644. eCollection 2021. Front Oncol. 2021. PMID: 33996552 Free PMC article.

7

A 10-year survival update on early-stage extranodal natural killer/T-cell lymphoma with 'sandwich' therapy.

Yang C, Zhang L, Jiang M, Xie L, Zhang H, Liu W, Zhang W, Zhao S, Zou L. Yang C, et al. Among authors: zou l. Acta Oncol. 2022 May;61(5):611-614. doi: 10.1080/0284186X.2022.2044516. Epub 2022 Feb 28. Acta Oncol. 2022. PMID: 35225152 No abstract available.

8

A Multicenter Study of 239 Patients Aged Over 70 Years With Diffuse Large B-Cell Lymphoma in China.

Yang C, Li Q, Xie K, Zhang Y, Xiang D, Han Y, Zou L. Yang C, et al. Among authors: zou l. Front Pharmacol. 2022 Jul 18;13:953808. doi: 10.3389/fphar.2022.953808. eCollection 2022. Front Pharmacol. 2022. PMID: 35924064 Free PMC article.

9

¹⁸F-FDG PET/CT Plays a Limited Role in Replacing Bone Marrow Biopsy for Newly Diagnosed Advanced-Stage Patients With Extranodal Natural Killer/T-Cell Lymphoma.

Yang C, Wu W, Zhou H, Zhao S, Tian R, Xiang M, Zou L. Yang C, et al. Among authors: zou l. Front Oncol. 2022 Jul 26;12:894804. doi: 10.3389/fonc.2022.894804. eCollection 2022. Front Oncol. 2022. PMID: 35965550 Free PMC article.

10

Radiomics-guided checkpoint inhibitor immunotherapy for precision medicine in cancer: A review for clinicians.

Zhou H, Luo Q, Wu W, Li N, Yang C, Zou L. Zhou H, et al. Among authors: zou l. Front Immunol. 2023 Mar 1;14:1088874. doi: 10.3389/fimmu.2023.1088874. eCollection 2023. Front Immunol. 2023. PMID: 36936913 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,140 results

Search Page

Filters